Chongkundang (001630.KS)
Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. The company was founded in 1941 and is based in Seoul, South Korea.
Company Info
Highlights
₩252.31B
₩954.38B
₩441.40B
₩40,700.00 - ₩59,010.54
₩50,000.00
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Chongkundang (001630.KS) returned 11.11% year-to-date (YTD) and -3.51% over the past 12 months. Over the past 10 years, 001630.KS returned -3.54% annually, underperforming the S&P 500 benchmark at 10.85%.
001630.KS
11.11%
14.35%
6.27%
-3.51%
-4.44%
-13.17%
-3.54%
^GSPC (Benchmark)
0.51%
5.49%
-2.00%
12.02%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of 001630.KS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -3.46% | -3.37% | -3.60% | 8.04% | 14.35% | 11.11% | |||||||
| 2024 | 1.86% | -2.16% | 1.19% | 3.18% | -8.28% | -4.60% | -1.48% | 9.23% | 0.86% | -4.62% | -8.06% | -4.36% | -17.12% |
| 2023 | 3.96% | -2.00% | -6.30% | 0.20% | -3.94% | -2.87% | 3.81% | 11.20% | -1.47% | -4.46% | 10.70% | 6.55% | 14.39% |
| 2022 | -10.98% | 0.59% | 4.67% | -3.35% | -5.34% | -13.57% | 5.47% | -0.00% | -15.72% | 4.17% | 5.14% | -1.56% | -28.97% |
| 2021 | -14.90% | -4.61% | 0.00% | 4.35% | 1.39% | -1.83% | -6.51% | -8.46% | -7.28% | -3.99% | -16.61% | 14.05% | -38.90% |
| 2020 | 11.39% | -5.33% | -0.94% | 8.06% | 4.82% | 0.42% | 2.92% | -2.02% | -11.98% | -8.73% | 14.20% | 16.21% | 27.72% |
| 2019 | 2.24% | 5.32% | 1.63% | 11.55% | 52.69% | -3.00% | -7.96% | -14.71% | 2.14% | 0.33% | 3.19% | 9.10% | 63.73% |
| 2018 | 7.86% | -7.29% | -0.55% | -3.19% | -3.72% | -3.57% | 0.15% | 2.00% | 4.98% | -19.28% | 12.30% | 1.33% | -11.95% |
| 2017 | -14.22% | 3.38% | 11.29% | 0.74% | 14.01% | -2.05% | -12.81% | 3.00% | 1.75% | -1.57% | 6.25% | 0.45% | 6.58% |
| 2016 | 3.60% | -15.65% | 3.09% | -11.50% | 3.05% | 7.24% | -4.60% | -12.86% | -5.90% | -13.20% | -3.61% | 9.89% | -36.64% |
| 2015 | -1.00% | 3.04% | 11.80% | 5.87% | 29.50% | 29.95% | -18.60% | -14.66% | 7.23% | -11.82% | 18.80% | 18.64% | 88.07% |
| 2014 | 7.08% | 6.06% | 17.96% | -12.50% | -6.34% | -7.84% | 0.35% | 12.66% | 21.65% | 33.22% | -11.45% | -13.11% | 42.62% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 001630.KS is 35, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Chongkundang (001630.KS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Chongkundang provided a 2.64% dividend yield over the last twelve months, with an annual payout of ₩1,400.00 per share. The company has been increasing its dividends for 7 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | ₩1,400.00 | ₩1,400.00 | ₩1,400.00 | ₩1,400.00 | ₩1,400.00 | ₩1,400.00 | ₩1,300.00 | ₩1,300.00 | ₩900.00 | ₩1,400.00 | ₩1,200.00 | ₩700.00 |
Dividend yield | 2.64% | 2.94% | 2.36% | 2.64% | 1.83% | 1.10% | 1.29% | 2.08% | 1.24% | 2.03% | 1.08% | 1.17% |
Monthly Dividends
The table displays the monthly dividend distributions for Chongkundang. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | |||||||
| 2024 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩1,400.00 | ₩1,400.00 |
| 2023 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩1,400.00 | ₩1,400.00 |
| 2022 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩1,400.00 | ₩1,400.00 |
| 2021 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩1,400.00 | ₩1,400.00 |
| 2020 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩1,400.00 | ₩1,400.00 |
| 2019 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩1,300.00 | ₩1,300.00 |
| 2018 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩1,300.00 | ₩1,300.00 |
| 2017 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩900.00 | ₩900.00 |
| 2016 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩1,400.00 | ₩1,400.00 |
| 2015 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩1,200.00 | ₩1,200.00 |
| 2014 | ₩700.00 | ₩700.00 |
Dividend Yield & Payout
Dividend Yield
Chongkundang has a dividend yield of 2.64%, which is quite average when compared to the overall market.
Payout Ratio
Chongkundang has a payout ratio of 21.68%, which is below the market average. This means Chongkundang returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Chongkundang. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Chongkundang was 95.10%, occurring on Mar 17, 2003. Recovery took 614 trading sessions.
The current Chongkundang drawdown is 57.58%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.1% | Mar 19, 1997 | 1443 | Mar 17, 2003 | 614 | Sep 7, 2005 | 2057 |
| -76.8% | Dec 1, 2005 | 717 | Oct 27, 2008 | 992 | Oct 12, 2012 | 1709 |
| -67.06% | Aug 5, 2020 | 1148 | Apr 9, 2025 | — | — | — |
| -59.96% | Jun 29, 2015 | 821 | Nov 1, 2018 | 434 | Aug 4, 2020 | 1255 |
| -46.78% | Dec 6, 2013 | 9 | Dec 18, 2013 | 204 | Oct 22, 2014 | 213 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Chongkundang over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Chongkundang, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 147.3% positive surprise.
Valuation
The Valuation section provides an overview of how Chongkundang is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for 001630.KS compared to other companies in the Drug Manufacturers - Specialty & Generic industry. 001630.KS currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 001630.KS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 001630.KS has a P/S ratio of 0.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 001630.KS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 001630.KS has a P/B value of 0.4. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |